Annual Obesity Symposium 2026

Friday, September 11, 2026, 9:00 AM - 3:00 PM, St. John’s Resort, Detroit, MI


AMA PRA Category 1 Credits™ (4.75 hours), AMA PRA Non-Physician Attendance (4.75 hours)

The Obesity Symposium: Advancing Obesity Care—Clinical Updates, Research Insights, and System Improvements is a multidisciplinary educational program designed to equip healthcare professionals with the latest knowledge and practical strategies in obesity management. This symposium will feature expert-led sessions on cutting-edge developments in obesity pharmacotherapy, including newly approved and emerging medications, their mechanisms of action, and considerations for clinical use. Attendees will also explore the complex relationship between obesity and cancer, with a focus on epidemiology, underlying biological mechanisms, and implications for prevention and screening. A dedicated session on women’s health will address the unique impact of obesity across the lifespan, including reproductive health, pregnancy, and menopause, while highlighting tailored treatment approaches. In addition, participants will gain insight into a system-wide quality improvement initiative, showcasing findings on obesity diagnosis and treatment, identifying gaps in care, and discussing strategies to enhance clinical practice. Through interactive discussions and a multidisciplinary panel, this symposium aims to foster collaboration, improve patient outcomes, and advance evidence-based, patient-centered obesity care.

1. Understand obesity as a chronic disease and apply updated treatment guidelines in clinical practice. The interactive educational setting also supports improved confidence in managing obesity with lifestyle interventions and emerging pharmacologic therapies.
2. Evaluate current updates in GLP-1 receptor agonists, pharmacotherapy, and metabolic surgery for optimizing chronic obesity management.Identify common barriers to dietary adherence in patients using GLP-1 therapies and apply strategies to improve nutritional compliance and weight loss outcomes.
3. Describe the intersection of obesity, cancer risk, and metabolic-bariatric surgery in improving long-term patient outcomes. Discuss the relationship between obesity, cardiometabolic health, and the role of metabolic surgery in disease prevention and treatment.
4. Apply evidence-based, multidisciplinary approaches—including pharmacologic, surgical, and behavioral strategies—to optimize long-term obesity management.ntegrate multidisciplinary perspectives to enhance comprehensive, team-based obesity care across surgical, medical, and nutrition domains. Quality improvement initiatives aimed at increasing the diagnosis and treatment of obesity, including key findings and implementation lessons.

If you are an employee of a pharmaceutical or device company, please see the exhibitor tab before registering.

Henry Ford Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement: Henry Ford Health designates this Live Activity for a maximum of 4.75 AMA PRA Category 1 Credit™(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Part 2: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participation completion information to ACCME For the purpose of granting ABIM MOC credit.

Accessibility Statement

The Henry Ford Health Office of Continuing Medical Education is committed to ensuring that its programs, services, goods, and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act and the ADA Amendments Act of 2008. If you have needs that require special accommodations, please contact [email protected]. 

Cancellation Policy

The Henry Ford Health Office of Continuing Medical Education reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties. Please send cancellation requests to [email protected]. 

Mitigation of Relevant Financial Relationships

Henry Ford Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Henry Ford Health has implemented mechanisms to identify and mitigate financial relationships with ineligible companies for all individuals in a position to control content of this activity. All relevant financial relationships have been mitigated prior to the commencement of this activity.

If your company is interested in supporting this event, please complete this form

If you are an employee of a pharmaceutical or device company and are interested in attending this event, your attendance must be organized by emailing [email protected]. Types of industry employees include PhDs, MSLs, pharmacologists, clinical research associates, sales reps, etc. Do not register on this webpage; your registration will be refunded.

Please visit our exhibitor website for more information.

If you have further inquiries, please email [email protected] and [email protected].